Loading stock data…
MEDP
$417.54-1.12 (-0.27%)
Market ClosedLast close May 1
Medpace Holdings, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Medpace Holdings, Inc. in the Healthcare sector is trading at $417.54. The stock is currently 34% below its 52-week high of $628.92, remaining 18.5% below its 200-day moving average. Technical signals show neutral RSI of 31 and bearish MACD signal, explaining why MEDP maintains its current current market pressure. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 31) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$417.54
Potential Upside
8.9%
Whystock Fair Value$454.82
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus12 analysts
Hold
Mean target$442.83+6.1%
Range$329.00 – $495.00
Fundamentals
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development proc...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$14.52B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
33.25
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.39
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
91.12%
Volume
Today's trading volume
250,143
Recent News
Medpace Holdings Inc. (MEDP): Bares Capital Trims Stake
We just covered the 10 Best Small-Cap Value Stocks to Buy According to Bares Capital and Medpace Holdings, Inc. (NASDAQ:MEDP) ranks 6th on this list. Medpace Holdings, Inc. (NASDAQ:MEDP) is a relatively recent addition to the 13F portfolio of Bares Capital. The fund first disclosed a stake in the company back in the first quarter […]
A Look At Medpace (MEDP) Valuation After Strong Q1 Results And Reaffirmed 2026 Revenue Guidance
Medpace Holdings (MEDP) shares are in focus after first quarter 2026 results and updated full year guidance highlighted strong reported revenue, ongoing project cancellations, and management’s decision to maintain its outlook. See our latest analysis for Medpace Holdings. At a share price of US$421.37, Medpace has a 1 day share price return of 2.64%. The 7 day and 90 day share price returns of 20.26% and 30.03% respectively indicate recent momentum, while the 1 year total shareholder return...
PACS or MEDP: Which Is the Better Value Stock Right Now?
PACS vs. MEDP: Which Stock Is the Better Value Option?
Down 15.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Medpace (MEDP)
The heavy selling pressure might have exhausted for Medpace (MEDP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Medpace Holdings Inc (MEDP) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Rising ...
Medpace Holdings Inc (MEDP) reports a robust 26.5% revenue increase, but faces challenges with high cancellation rates impacting future growth.